nodes	percent_of_prediction	percent_of_DWPC	metapath
Zalcitabine—SLC22A6—Methazolamide—glaucoma	0.0779	0.126	CbGbCtD
Zalcitabine—CYP2D6—Carteolol—glaucoma	0.0639	0.103	CbGbCtD
Zalcitabine—SLC22A6—Acetazolamide—glaucoma	0.0623	0.101	CbGbCtD
Zalcitabine—CYP2D6—Betaxolol—glaucoma	0.0432	0.0698	CbGbCtD
Zalcitabine—CYP2C9—Diclofenamide—glaucoma	0.0415	0.0672	CbGbCtD
Zalcitabine—CYP2C9—Dorzolamide—glaucoma	0.0401	0.0649	CbGbCtD
Zalcitabine—CYP3A5—Clonidine—glaucoma	0.0386	0.0624	CbGbCtD
Zalcitabine—CYP2C9—Methazolamide—glaucoma	0.0358	0.0579	CbGbCtD
Zalcitabine—CYP2D6—Methazolamide—glaucoma	0.0327	0.0529	CbGbCtD
Zalcitabine—CYP3A4—Pilocarpine—glaucoma	0.0308	0.0498	CbGbCtD
Zalcitabine—CYP2D6—Timolol—glaucoma	0.0278	0.045	CbGbCtD
Zalcitabine—CYP3A4—Brinzolamide—glaucoma	0.0242	0.0391	CbGbCtD
Zalcitabine—CYP2D6—Clonidine—glaucoma	0.0236	0.0383	CbGbCtD
Zalcitabine—CYP3A4—Dorzolamide—glaucoma	0.0233	0.0377	CbGbCtD
Zalcitabine—CYP3A4—Methazolamide—glaucoma	0.0208	0.0336	CbGbCtD
Zalcitabine—CYP3A4—Acetazolamide—glaucoma	0.0166	0.0269	CbGbCtD
Zalcitabine—CYP3A4—Clonidine—glaucoma	0.015	0.0243	CbGbCtD
Zalcitabine—SLC29A2—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000325	0.0333	CbGpPWpGaD
Zalcitabine—SLC29A1—Fluoropyrimidine Activity—MTHFR—glaucoma	0.000281	0.0288	CbGpPWpGaD
Zalcitabine—DCK—Nucleotide metabolism—TXN—glaucoma	0.000272	0.0279	CbGpPWpGaD
Zalcitabine—SLC29A2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000245	0.0251	CbGpPWpGaD
Zalcitabine—SLC29A1—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000225	0.0231	CbGpPWpGaD
Zalcitabine—SLC29A2—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000217	0.0222	CbGpPWpGaD
Zalcitabine—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.00021	0.0215	CbGpPWpGaD
Zalcitabine—CYP3A43—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000204	0.0209	CbGpPWpGaD
Zalcitabine—CYP3A43—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000202	0.0207	CbGpPWpGaD
Zalcitabine—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.000191	0.0196	CbGpPWpGaD
Zalcitabine—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.000189	0.0193	CbGpPWpGaD
Zalcitabine—Dyspnoea—Travoprost—glaucoma	0.000186	0.0005	CcSEcCtD
Zalcitabine—Dysuria—Timolol—glaucoma	0.000185	0.000498	CcSEcCtD
Zalcitabine—Dyspepsia—Dorzolamide—glaucoma	0.000185	0.000496	CcSEcCtD
Zalcitabine—Dyspnoea—Brinzolamide—glaucoma	0.000184	0.000494	CcSEcCtD
Zalcitabine—Dyspepsia—Travoprost—glaucoma	0.000184	0.000494	CcSEcCtD
Zalcitabine—Asthenia—Apraclonidine—glaucoma	0.000184	0.000493	CcSEcCtD
Zalcitabine—Somnolence—Brinzolamide—glaucoma	0.000183	0.000493	CcSEcCtD
Zalcitabine—Vision blurred—Clonidine—glaucoma	0.000183	0.000491	CcSEcCtD
Zalcitabine—Decreased appetite—Dorzolamide—glaucoma	0.000182	0.00049	CcSEcCtD
Zalcitabine—Urticaria—Acetazolamide—glaucoma	0.000182	0.000489	CcSEcCtD
Zalcitabine—Tremor—Clonidine—glaucoma	0.000182	0.000488	CcSEcCtD
Zalcitabine—Dyspepsia—Brinzolamide—glaucoma	0.000182	0.000488	CcSEcCtD
Zalcitabine—Eye disorder—Betaxolol—glaucoma	0.000181	0.000487	CcSEcCtD
Zalcitabine—Pruritus—Apraclonidine—glaucoma	0.000181	0.000486	CcSEcCtD
Zalcitabine—Body temperature increased—Acetazolamide—glaucoma	0.000181	0.000486	CcSEcCtD
Zalcitabine—Fatigue—Dorzolamide—glaucoma	0.000181	0.000486	CcSEcCtD
Zalcitabine—Tinnitus—Betaxolol—glaucoma	0.000181	0.000486	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000181	0.000485	CcSEcCtD
Zalcitabine—Fatigue—Travoprost—glaucoma	0.00018	0.000484	CcSEcCtD
Zalcitabine—Flushing—Betaxolol—glaucoma	0.00018	0.000484	CcSEcCtD
Zalcitabine—Ill-defined disorder—Clonidine—glaucoma	0.00018	0.000484	CcSEcCtD
Zalcitabine—Pain—Dorzolamide—glaucoma	0.000179	0.000482	CcSEcCtD
Zalcitabine—Insomnia—Pilocarpine—glaucoma	0.000179	0.000482	CcSEcCtD
Zalcitabine—Decreased appetite—Brinzolamide—glaucoma	0.000179	0.000482	CcSEcCtD
Zalcitabine—Weight decreased—Timolol—glaucoma	0.000179	0.000481	CcSEcCtD
Zalcitabine—Pain—Travoprost—glaucoma	0.000179	0.00048	CcSEcCtD
Zalcitabine—Hyperglycaemia—Timolol—glaucoma	0.000179	0.00048	CcSEcCtD
Zalcitabine—Agitation—Clonidine—glaucoma	0.000178	0.000479	CcSEcCtD
Zalcitabine—Asthenia—Bimatoprost—glaucoma	0.000178	0.000478	CcSEcCtD
Zalcitabine—Fatigue—Brinzolamide—glaucoma	0.000178	0.000478	CcSEcCtD
Zalcitabine—Dyspnoea—Pilocarpine—glaucoma	0.000177	0.000475	CcSEcCtD
Zalcitabine—Pain—Brinzolamide—glaucoma	0.000176	0.000474	CcSEcCtD
Zalcitabine—Somnolence—Pilocarpine—glaucoma	0.000176	0.000474	CcSEcCtD
Zalcitabine—Depression—Timolol—glaucoma	0.000176	0.000473	CcSEcCtD
Zalcitabine—Pruritus—Bimatoprost—glaucoma	0.000176	0.000472	CcSEcCtD
Zalcitabine—Diarrhoea—Apraclonidine—glaucoma	0.000175	0.00047	CcSEcCtD
Zalcitabine—Malaise—Clonidine—glaucoma	0.000175	0.00047	CcSEcCtD
Zalcitabine—Dyspepsia—Pilocarpine—glaucoma	0.000175	0.000469	CcSEcCtD
Zalcitabine—Chills—Betaxolol—glaucoma	0.000174	0.000468	CcSEcCtD
Zalcitabine—Syncope—Clonidine—glaucoma	0.000174	0.000467	CcSEcCtD
Zalcitabine—Arrhythmia—Betaxolol—glaucoma	0.000173	0.000466	CcSEcCtD
Zalcitabine—Feeling abnormal—Dorzolamide—glaucoma	0.000173	0.000465	CcSEcCtD
Zalcitabine—Decreased appetite—Pilocarpine—glaucoma	0.000172	0.000463	CcSEcCtD
Zalcitabine—Feeling abnormal—Travoprost—glaucoma	0.000172	0.000463	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Dorzolamide—glaucoma	0.000172	0.000461	CcSEcCtD
Zalcitabine—Alopecia—Betaxolol—glaucoma	0.000171	0.000461	CcSEcCtD
Zalcitabine—Palpitations—Clonidine—glaucoma	0.000171	0.000461	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Travoprost—glaucoma	0.000171	0.000459	CcSEcCtD
Zalcitabine—Loss of consciousness—Clonidine—glaucoma	0.000171	0.000458	CcSEcCtD
Zalcitabine—Feeling abnormal—Brinzolamide—glaucoma	0.00017	0.000457	CcSEcCtD
Zalcitabine—Pain—Pilocarpine—glaucoma	0.00017	0.000456	CcSEcCtD
Zalcitabine—SLC29A1—Transmembrane transport of small molecules—PEX19—glaucoma	0.000169	0.0174	CbGpPWpGaD
Zalcitabine—Cough—Clonidine—glaucoma	0.000169	0.000455	CcSEcCtD
Zalcitabine—Dizziness—Apraclonidine—glaucoma	0.000169	0.000455	CcSEcCtD
Zalcitabine—Urticaria—Dorzolamide—glaucoma	0.000167	0.000448	CcSEcCtD
Zalcitabine—Epistaxis—Timolol—glaucoma	0.000167	0.000447	CcSEcCtD
Zalcitabine—Body temperature increased—Dorzolamide—glaucoma	0.000166	0.000446	CcSEcCtD
Zalcitabine—Abdominal pain—Dorzolamide—glaucoma	0.000166	0.000446	CcSEcCtD
Zalcitabine—Tension—Betaxolol—glaucoma	0.000166	0.000445	CcSEcCtD
Zalcitabine—Sinusitis—Timolol—glaucoma	0.000166	0.000445	CcSEcCtD
Zalcitabine—CYP3A43—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000166	0.017	CbGpPWpGaD
Zalcitabine—Dysgeusia—Betaxolol—glaucoma	0.000165	0.000444	CcSEcCtD
Zalcitabine—SLC29A2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000165	0.0169	CbGpPWpGaD
Zalcitabine—Arthralgia—Clonidine—glaucoma	0.000165	0.000444	CcSEcCtD
Zalcitabine—Abdominal pain—Travoprost—glaucoma	0.000165	0.000444	CcSEcCtD
Zalcitabine—Anxiety—Clonidine—glaucoma	0.000165	0.000442	CcSEcCtD
Zalcitabine—Asthenia—Acetazolamide—glaucoma	0.000164	0.000441	CcSEcCtD
Zalcitabine—Dizziness—Bimatoprost—glaucoma	0.000164	0.000441	CcSEcCtD
Zalcitabine—Nervousness—Betaxolol—glaucoma	0.000164	0.000441	CcSEcCtD
Zalcitabine—Urticaria—Brinzolamide—glaucoma	0.000164	0.00044	CcSEcCtD
Zalcitabine—Feeling abnormal—Pilocarpine—glaucoma	0.000163	0.000439	CcSEcCtD
Zalcitabine—Discomfort—Clonidine—glaucoma	0.000163	0.000438	CcSEcCtD
Zalcitabine—Vomiting—Apraclonidine—glaucoma	0.000163	0.000437	CcSEcCtD
Zalcitabine—Muscle spasms—Betaxolol—glaucoma	0.000162	0.000436	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Pilocarpine—glaucoma	0.000162	0.000436	CcSEcCtD
Zalcitabine—Hypersensitivity—Brimonidine—glaucoma	0.000162	0.000435	CcSEcCtD
Zalcitabine—Dry mouth—Clonidine—glaucoma	0.000162	0.000434	CcSEcCtD
Zalcitabine—Dermatitis—Apraclonidine—glaucoma	0.000161	0.000433	CcSEcCtD
Zalcitabine—Headache—Apraclonidine—glaucoma	0.00016	0.000431	CcSEcCtD
Zalcitabine—SLC22A7—Fluoropyrimidine Activity—MTHFR—glaucoma	0.00016	0.0164	CbGpPWpGaD
Zalcitabine—Confusional state—Clonidine—glaucoma	0.00016	0.000429	CcSEcCtD
Zalcitabine—Vision blurred—Betaxolol—glaucoma	0.000159	0.000428	CcSEcCtD
Zalcitabine—Rhinitis—Timolol—glaucoma	0.000159	0.000427	CcSEcCtD
Zalcitabine—SLC29A2—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000159	0.0163	CbGpPWpGaD
Zalcitabine—Oedema—Clonidine—glaucoma	0.000158	0.000425	CcSEcCtD
Zalcitabine—Tremor—Betaxolol—glaucoma	0.000158	0.000425	CcSEcCtD
Zalcitabine—Hallucination—Timolol—glaucoma	0.000158	0.000424	CcSEcCtD
Zalcitabine—Asthenia—Brimonidine—glaucoma	0.000158	0.000424	CcSEcCtD
Zalcitabine—Infection—Clonidine—glaucoma	0.000157	0.000423	CcSEcCtD
Zalcitabine—Abdominal pain—Pilocarpine—glaucoma	0.000157	0.000421	CcSEcCtD
Zalcitabine—Body temperature increased—Pilocarpine—glaucoma	0.000157	0.000421	CcSEcCtD
Zalcitabine—Ill-defined disorder—Betaxolol—glaucoma	0.000157	0.000421	CcSEcCtD
Zalcitabine—Diarrhoea—Acetazolamide—glaucoma	0.000157	0.000421	CcSEcCtD
Zalcitabine—Rash—Bimatoprost—glaucoma	0.000156	0.00042	CcSEcCtD
Zalcitabine—Dermatitis—Bimatoprost—glaucoma	0.000156	0.00042	CcSEcCtD
Zalcitabine—Anaemia—Betaxolol—glaucoma	0.000156	0.000419	CcSEcCtD
Zalcitabine—Shock—Clonidine—glaucoma	0.000156	0.000419	CcSEcCtD
Zalcitabine—Pruritus—Brimonidine—glaucoma	0.000155	0.000418	CcSEcCtD
Zalcitabine—Headache—Bimatoprost—glaucoma	0.000155	0.000418	CcSEcCtD
Zalcitabine—Thrombocytopenia—Clonidine—glaucoma	0.000155	0.000417	CcSEcCtD
Zalcitabine—Hypersensitivity—Dorzolamide—glaucoma	0.000155	0.000415	CcSEcCtD
Zalcitabine—Tachycardia—Clonidine—glaucoma	0.000155	0.000415	CcSEcCtD
Zalcitabine—Hypersensitivity—Travoprost—glaucoma	0.000154	0.000414	CcSEcCtD
Zalcitabine—Skin disorder—Clonidine—glaucoma	0.000154	0.000413	CcSEcCtD
Zalcitabine—Hyperhidrosis—Clonidine—glaucoma	0.000153	0.000411	CcSEcCtD
Zalcitabine—Visual impairment—Timolol—glaucoma	0.000153	0.00041	CcSEcCtD
Zalcitabine—Malaise—Betaxolol—glaucoma	0.000152	0.000409	CcSEcCtD
Zalcitabine—Hypersensitivity—Brinzolamide—glaucoma	0.000152	0.000408	CcSEcCtD
Zalcitabine—Vertigo—Betaxolol—glaucoma	0.000152	0.000408	CcSEcCtD
Zalcitabine—Syncope—Betaxolol—glaucoma	0.000151	0.000407	CcSEcCtD
Zalcitabine—Dizziness—Acetazolamide—glaucoma	0.000151	0.000407	CcSEcCtD
Zalcitabine—Anorexia—Clonidine—glaucoma	0.000151	0.000406	CcSEcCtD
Zalcitabine—Asthenia—Dorzolamide—glaucoma	0.000151	0.000404	CcSEcCtD
Zalcitabine—SLC29A1—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.00015	0.0154	CbGpPWpGaD
Zalcitabine—Asthenia—Travoprost—glaucoma	0.00015	0.000403	CcSEcCtD
Zalcitabine—Palpitations—Betaxolol—glaucoma	0.000149	0.000401	CcSEcCtD
Zalcitabine—Pruritus—Dorzolamide—glaucoma	0.000148	0.000399	CcSEcCtD
Zalcitabine—Loss of consciousness—Betaxolol—glaucoma	0.000148	0.000399	CcSEcCtD
Zalcitabine—Eye disorder—Timolol—glaucoma	0.000148	0.000398	CcSEcCtD
Zalcitabine—Asthenia—Brinzolamide—glaucoma	0.000148	0.000398	CcSEcCtD
Zalcitabine—Pruritus—Travoprost—glaucoma	0.000148	0.000397	CcSEcCtD
Zalcitabine—Tinnitus—Timolol—glaucoma	0.000148	0.000397	CcSEcCtD
Zalcitabine—Cough—Betaxolol—glaucoma	0.000147	0.000396	CcSEcCtD
Zalcitabine—Hypersensitivity—Pilocarpine—glaucoma	0.000146	0.000392	CcSEcCtD
Zalcitabine—Pruritus—Brinzolamide—glaucoma	0.000146	0.000392	CcSEcCtD
Zalcitabine—Vomiting—Acetazolamide—glaucoma	0.000146	0.000391	CcSEcCtD
Zalcitabine—Dizziness—Brimonidine—glaucoma	0.000145	0.00039	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Clonidine—glaucoma	0.000144	0.000388	CcSEcCtD
Zalcitabine—Arthralgia—Betaxolol—glaucoma	0.000144	0.000386	CcSEcCtD
Zalcitabine—Myalgia—Betaxolol—glaucoma	0.000144	0.000386	CcSEcCtD
Zalcitabine—Diarrhoea—Dorzolamide—glaucoma	0.000144	0.000386	CcSEcCtD
Zalcitabine—Headache—Acetazolamide—glaucoma	0.000143	0.000385	CcSEcCtD
Zalcitabine—Anxiety—Betaxolol—glaucoma	0.000143	0.000385	CcSEcCtD
Zalcitabine—Insomnia—Clonidine—glaucoma	0.000143	0.000385	CcSEcCtD
Zalcitabine—Diarrhoea—Travoprost—glaucoma	0.000143	0.000384	CcSEcCtD
Zalcitabine—Asthenia—Pilocarpine—glaucoma	0.000142	0.000382	CcSEcCtD
Zalcitabine—Discomfort—Betaxolol—glaucoma	0.000142	0.000382	CcSEcCtD
Zalcitabine—Arrhythmia—Timolol—glaucoma	0.000142	0.00038	CcSEcCtD
Zalcitabine—Dyspnoea—Clonidine—glaucoma	0.000141	0.000379	CcSEcCtD
Zalcitabine—Diarrhoea—Brinzolamide—glaucoma	0.000141	0.000379	CcSEcCtD
Zalcitabine—Somnolence—Clonidine—glaucoma	0.000141	0.000378	CcSEcCtD
Zalcitabine—Dry mouth—Betaxolol—glaucoma	0.000141	0.000378	CcSEcCtD
Zalcitabine—Pruritus—Pilocarpine—glaucoma	0.00014	0.000377	CcSEcCtD
Zalcitabine—Alopecia—Timolol—glaucoma	0.00014	0.000376	CcSEcCtD
Zalcitabine—Confusional state—Betaxolol—glaucoma	0.000139	0.000373	CcSEcCtD
Zalcitabine—Dizziness—Dorzolamide—glaucoma	0.000139	0.000373	CcSEcCtD
Zalcitabine—Rash—Brimonidine—glaucoma	0.000139	0.000372	CcSEcCtD
Zalcitabine—Dermatitis—Brimonidine—glaucoma	0.000138	0.000372	CcSEcCtD
Zalcitabine—Dizziness—Travoprost—glaucoma	0.000138	0.000371	CcSEcCtD
Zalcitabine—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000138	0.0141	CbGpPWpGaD
Zalcitabine—Oedema—Betaxolol—glaucoma	0.000138	0.00037	CcSEcCtD
Zalcitabine—CYP3A5—Tamoxifen metabolism—CYP1B1—glaucoma	0.000138	0.0141	CbGpPWpGaD
Zalcitabine—Headache—Brimonidine—glaucoma	0.000138	0.00037	CcSEcCtD
Zalcitabine—Decreased appetite—Clonidine—glaucoma	0.000138	0.00037	CcSEcCtD
Zalcitabine—Infection—Betaxolol—glaucoma	0.000137	0.000368	CcSEcCtD
Zalcitabine—Fatigue—Clonidine—glaucoma	0.000137	0.000367	CcSEcCtD
Zalcitabine—Dizziness—Brinzolamide—glaucoma	0.000136	0.000367	CcSEcCtD
Zalcitabine—Diarrhoea—Pilocarpine—glaucoma	0.000136	0.000364	CcSEcCtD
Zalcitabine—Shock—Betaxolol—glaucoma	0.000136	0.000364	CcSEcCtD
Zalcitabine—Tension—Timolol—glaucoma	0.000135	0.000364	CcSEcCtD
Zalcitabine—Pain—Clonidine—glaucoma	0.000135	0.000364	CcSEcCtD
Zalcitabine—Dysgeusia—Timolol—glaucoma	0.000135	0.000363	CcSEcCtD
Zalcitabine—Thrombocytopenia—Betaxolol—glaucoma	0.000135	0.000363	CcSEcCtD
Zalcitabine—Tachycardia—Betaxolol—glaucoma	0.000135	0.000361	CcSEcCtD
Zalcitabine—Nervousness—Timolol—glaucoma	0.000134	0.00036	CcSEcCtD
Zalcitabine—Skin disorder—Betaxolol—glaucoma	0.000134	0.00036	CcSEcCtD
Zalcitabine—Vomiting—Dorzolamide—glaucoma	0.000133	0.000358	CcSEcCtD
Zalcitabine—Hyperhidrosis—Betaxolol—glaucoma	0.000133	0.000358	CcSEcCtD
Zalcitabine—Rash—Dorzolamide—glaucoma	0.000132	0.000355	CcSEcCtD
Zalcitabine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.000132	0.0136	CbGpPWpGaD
Zalcitabine—Dermatitis—Dorzolamide—glaucoma	0.000132	0.000355	CcSEcCtD
Zalcitabine—Rash—Travoprost—glaucoma	0.000132	0.000354	CcSEcCtD
Zalcitabine—Dermatitis—Travoprost—glaucoma	0.000132	0.000354	CcSEcCtD
Zalcitabine—Headache—Dorzolamide—glaucoma	0.000131	0.000353	CcSEcCtD
Zalcitabine—Anorexia—Betaxolol—glaucoma	0.000131	0.000353	CcSEcCtD
Zalcitabine—Vomiting—Brinzolamide—glaucoma	0.000131	0.000352	CcSEcCtD
Zalcitabine—Dizziness—Pilocarpine—glaucoma	0.000131	0.000352	CcSEcCtD
Zalcitabine—Headache—Travoprost—glaucoma	0.000131	0.000352	CcSEcCtD
Zalcitabine—Feeling abnormal—Clonidine—glaucoma	0.00013	0.000351	CcSEcCtD
Zalcitabine—Rash—Brinzolamide—glaucoma	0.00013	0.000349	CcSEcCtD
Zalcitabine—Vision blurred—Timolol—glaucoma	0.00013	0.000349	CcSEcCtD
Zalcitabine—Dermatitis—Brinzolamide—glaucoma	0.00013	0.000349	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Clonidine—glaucoma	0.000129	0.000348	CcSEcCtD
Zalcitabine—Headache—Brinzolamide—glaucoma	0.000129	0.000347	CcSEcCtD
Zalcitabine—SLC22A7—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000128	0.0132	CbGpPWpGaD
Zalcitabine—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.000126	0.0129	CbGpPWpGaD
Zalcitabine—Vomiting—Pilocarpine—glaucoma	0.000126	0.000339	CcSEcCtD
Zalcitabine—Urticaria—Clonidine—glaucoma	0.000126	0.000338	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000126	0.000337	CcSEcCtD
Zalcitabine—Body temperature increased—Clonidine—glaucoma	0.000125	0.000336	CcSEcCtD
Zalcitabine—Abdominal pain—Clonidine—glaucoma	0.000125	0.000336	CcSEcCtD
Zalcitabine—Rash—Pilocarpine—glaucoma	0.000125	0.000336	CcSEcCtD
Zalcitabine—Dermatitis—Pilocarpine—glaucoma	0.000125	0.000336	CcSEcCtD
Zalcitabine—Insomnia—Betaxolol—glaucoma	0.000125	0.000335	CcSEcCtD
Zalcitabine—Headache—Pilocarpine—glaucoma	0.000124	0.000334	CcSEcCtD
Zalcitabine—Vertigo—Timolol—glaucoma	0.000124	0.000333	CcSEcCtD
Zalcitabine—Syncope—Timolol—glaucoma	0.000124	0.000332	CcSEcCtD
Zalcitabine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000123	0.0126	CbGpPWpGaD
Zalcitabine—Dyspnoea—Betaxolol—glaucoma	0.000123	0.00033	CcSEcCtD
Zalcitabine—Palpitations—Timolol—glaucoma	0.000122	0.000328	CcSEcCtD
Zalcitabine—Dyspepsia—Betaxolol—glaucoma	0.000121	0.000326	CcSEcCtD
Zalcitabine—Loss of consciousness—Timolol—glaucoma	0.000121	0.000326	CcSEcCtD
Zalcitabine—Cough—Timolol—glaucoma	0.00012	0.000324	CcSEcCtD
Zalcitabine—Decreased appetite—Betaxolol—glaucoma	0.00012	0.000322	CcSEcCtD
Zalcitabine—Hypertension—Timolol—glaucoma	0.000119	0.00032	CcSEcCtD
Zalcitabine—Fatigue—Betaxolol—glaucoma	0.000119	0.000319	CcSEcCtD
Zalcitabine—Pain—Betaxolol—glaucoma	0.000118	0.000317	CcSEcCtD
Zalcitabine—Myalgia—Timolol—glaucoma	0.000117	0.000316	CcSEcCtD
Zalcitabine—Arthralgia—Timolol—glaucoma	0.000117	0.000316	CcSEcCtD
Zalcitabine—Anxiety—Timolol—glaucoma	0.000117	0.000315	CcSEcCtD
Zalcitabine—Hypersensitivity—Clonidine—glaucoma	0.000117	0.000313	CcSEcCtD
Zalcitabine—Discomfort—Timolol—glaucoma	0.000116	0.000312	CcSEcCtD
Zalcitabine—Dry mouth—Timolol—glaucoma	0.000115	0.000309	CcSEcCtD
Zalcitabine—SLC29A1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000114	0.0117	CbGpPWpGaD
Zalcitabine—Asthenia—Clonidine—glaucoma	0.000114	0.000305	CcSEcCtD
Zalcitabine—Feeling abnormal—Betaxolol—glaucoma	0.000114	0.000305	CcSEcCtD
Zalcitabine—Confusional state—Timolol—glaucoma	0.000114	0.000305	CcSEcCtD
Zalcitabine—Oedema—Timolol—glaucoma	0.000113	0.000303	CcSEcCtD
Zalcitabine—Pruritus—Clonidine—glaucoma	0.000112	0.000301	CcSEcCtD
Zalcitabine—Infection—Timolol—glaucoma	0.000112	0.000301	CcSEcCtD
Zalcitabine—Shock—Timolol—glaucoma	0.000111	0.000298	CcSEcCtD
Zalcitabine—CYP3A43—Biological oxidations—GSTT1—glaucoma	0.00011	0.0113	CbGpPWpGaD
Zalcitabine—SLC29A2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.00011	0.0113	CbGpPWpGaD
Zalcitabine—SLC29A1—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.00011	0.0113	CbGpPWpGaD
Zalcitabine—Urticaria—Betaxolol—glaucoma	0.00011	0.000294	CcSEcCtD
Zalcitabine—Skin disorder—Timolol—glaucoma	0.000109	0.000294	CcSEcCtD
Zalcitabine—Body temperature increased—Betaxolol—glaucoma	0.000109	0.000293	CcSEcCtD
Zalcitabine—Hyperhidrosis—Timolol—glaucoma	0.000109	0.000293	CcSEcCtD
Zalcitabine—Diarrhoea—Clonidine—glaucoma	0.000108	0.000291	CcSEcCtD
Zalcitabine—Anorexia—Timolol—glaucoma	0.000107	0.000288	CcSEcCtD
Zalcitabine—SLC29A1—Fluoropyrimidine Activity—TP53—glaucoma	0.000107	0.0109	CbGpPWpGaD
Zalcitabine—Dizziness—Clonidine—glaucoma	0.000105	0.000281	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Timolol—glaucoma	0.000103	0.000276	CcSEcCtD
Zalcitabine—Insomnia—Timolol—glaucoma	0.000102	0.000274	CcSEcCtD
Zalcitabine—Hypersensitivity—Betaxolol—glaucoma	0.000102	0.000273	CcSEcCtD
Zalcitabine—Vomiting—Clonidine—glaucoma	0.000101	0.00027	CcSEcCtD
Zalcitabine—Dyspnoea—Timolol—glaucoma	0.0001	0.00027	CcSEcCtD
Zalcitabine—Somnolence—Timolol—glaucoma	0.0001	0.000269	CcSEcCtD
Zalcitabine—Rash—Clonidine—glaucoma	9.98e-05	0.000268	CcSEcCtD
Zalcitabine—Dermatitis—Clonidine—glaucoma	9.97e-05	0.000268	CcSEcCtD
Zalcitabine—Headache—Clonidine—glaucoma	9.92e-05	0.000267	CcSEcCtD
Zalcitabine—Dyspepsia—Timolol—glaucoma	9.91e-05	0.000266	CcSEcCtD
Zalcitabine—Asthenia—Betaxolol—glaucoma	9.89e-05	0.000266	CcSEcCtD
Zalcitabine—CYP2D6—Tamoxifen metabolism—CYP1B1—glaucoma	9.79e-05	0.01	CbGpPWpGaD
Zalcitabine—Decreased appetite—Timolol—glaucoma	9.79e-05	0.000263	CcSEcCtD
Zalcitabine—Pruritus—Betaxolol—glaucoma	9.75e-05	0.000262	CcSEcCtD
Zalcitabine—CYP2C9—Tamoxifen metabolism—CYP1B1—glaucoma	9.71e-05	0.00995	CbGpPWpGaD
Zalcitabine—Fatigue—Timolol—glaucoma	9.71e-05	0.000261	CcSEcCtD
Zalcitabine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	9.68e-05	0.00992	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—PEX19—glaucoma	9.66e-05	0.0099	CbGpPWpGaD
Zalcitabine—Pain—Timolol—glaucoma	9.63e-05	0.000259	CcSEcCtD
Zalcitabine—Diarrhoea—Betaxolol—glaucoma	9.43e-05	0.000253	CcSEcCtD
Zalcitabine—Feeling abnormal—Timolol—glaucoma	9.28e-05	0.000249	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Timolol—glaucoma	9.21e-05	0.000247	CcSEcCtD
Zalcitabine—Dizziness—Betaxolol—glaucoma	9.11e-05	0.000245	CcSEcCtD
Zalcitabine—SLC22A6—SLC-mediated transmembrane transport—SLC4A4—glaucoma	9.01e-05	0.00923	CbGpPWpGaD
Zalcitabine—Urticaria—Timolol—glaucoma	8.95e-05	0.00024	CcSEcCtD
Zalcitabine—Abdominal pain—Timolol—glaucoma	8.9e-05	0.000239	CcSEcCtD
Zalcitabine—Body temperature increased—Timolol—glaucoma	8.9e-05	0.000239	CcSEcCtD
Zalcitabine—CYP3A43—Biological oxidations—CYP1B1—glaucoma	8.8e-05	0.00901	CbGpPWpGaD
Zalcitabine—Vomiting—Betaxolol—glaucoma	8.76e-05	0.000235	CcSEcCtD
Zalcitabine—Rash—Betaxolol—glaucoma	8.69e-05	0.000234	CcSEcCtD
Zalcitabine—Dermatitis—Betaxolol—glaucoma	8.68e-05	0.000233	CcSEcCtD
Zalcitabine—CYP3A43—Metapathway biotransformation—CYP1B1—glaucoma	8.67e-05	0.00889	CbGpPWpGaD
Zalcitabine—Headache—Betaxolol—glaucoma	8.64e-05	0.000232	CcSEcCtD
Zalcitabine—SLC22A7—SLC-mediated transmembrane transport—SLC6A13—glaucoma	8.57e-05	0.00878	CbGpPWpGaD
Zalcitabine—Hypersensitivity—Timolol—glaucoma	8.3e-05	0.000223	CcSEcCtD
Zalcitabine—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	8.23e-05	0.00843	CbGpPWpGaD
Zalcitabine—CYP3A7—Oxidation by Cytochrome P450—CYP1B1—glaucoma	8.12e-05	0.00832	CbGpPWpGaD
Zalcitabine—Asthenia—Timolol—glaucoma	8.08e-05	0.000217	CcSEcCtD
Zalcitabine—SLC29A2—Transmembrane transport of small molecules—SLC6A1—glaucoma	8.07e-05	0.00827	CbGpPWpGaD
Zalcitabine—Pruritus—Timolol—glaucoma	7.97e-05	0.000214	CcSEcCtD
Zalcitabine—DCK—Metabolism—CA5A—glaucoma	7.86e-05	0.00805	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—NARFL—glaucoma	7.86e-05	0.00805	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—CA5A—glaucoma	7.74e-05	0.00793	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—NARFL—glaucoma	7.74e-05	0.00793	CbGpPWpGaD
Zalcitabine—Diarrhoea—Timolol—glaucoma	7.7e-05	0.000207	CcSEcCtD
Zalcitabine—SLC29A1—Transmembrane transport of small molecules—SLC6A13—glaucoma	7.64e-05	0.00783	CbGpPWpGaD
Zalcitabine—CYP2D6—Melatonin metabolism and effects—CYP1B1—glaucoma	7.56e-05	0.00775	CbGpPWpGaD
Zalcitabine—Dizziness—Timolol—glaucoma	7.45e-05	0.0002	CcSEcCtD
Zalcitabine—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	7.24e-05	0.00742	CbGpPWpGaD
Zalcitabine—Vomiting—Timolol—glaucoma	7.16e-05	0.000192	CcSEcCtD
Zalcitabine—Rash—Timolol—glaucoma	7.1e-05	0.000191	CcSEcCtD
Zalcitabine—Dermatitis—Timolol—glaucoma	7.09e-05	0.000191	CcSEcCtD
Zalcitabine—Headache—Timolol—glaucoma	7.05e-05	0.00019	CcSEcCtD
Zalcitabine—CYP3A43—Biological oxidations—GSTM1—glaucoma	7.03e-05	0.00721	CbGpPWpGaD
Zalcitabine—CYP3A43—Metapathway biotransformation—GSTM1—glaucoma	6.93e-05	0.00711	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—PEX19—glaucoma	6.78e-05	0.00694	CbGpPWpGaD
Zalcitabine—CYP3A7—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	6.67e-05	0.00683	CbGpPWpGaD
Zalcitabine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	6.6e-05	0.00677	CbGpPWpGaD
Zalcitabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1B—glaucoma	6.58e-05	0.00674	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—SLC4A4—glaucoma	6.52e-05	0.00669	CbGpPWpGaD
Zalcitabine—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	6.4e-05	0.00656	CbGpPWpGaD
Zalcitabine—SLC22A7—SLC-mediated transmembrane transport—SLC6A1—glaucoma	6.27e-05	0.00643	CbGpPWpGaD
Zalcitabine—CYP2D6—Melatonin metabolism and effects—EDN1—glaucoma	6.12e-05	0.00627	CbGpPWpGaD
Zalcitabine—SLC22A7—Fluoropyrimidine Activity—TP53—glaucoma	6.08e-05	0.00623	CbGpPWpGaD
Zalcitabine—SLC22A6—SLC-mediated transmembrane transport—SLC6A13—glaucoma	6.01e-05	0.00616	CbGpPWpGaD
Zalcitabine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	5.95e-05	0.00609	CbGpPWpGaD
Zalcitabine—CYP3A5—Oxidation by Cytochrome P450—CYP1B1—glaucoma	5.87e-05	0.00601	CbGpPWpGaD
Zalcitabine—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	5.79e-05	0.00593	CbGpPWpGaD
Zalcitabine—SLC29A1—Transmembrane transport of small molecules—SLC6A1—glaucoma	5.59e-05	0.00573	CbGpPWpGaD
Zalcitabine—CYP2D6—Melatonin metabolism and effects—APOE—glaucoma	4.98e-05	0.0051	CbGpPWpGaD
Zalcitabine—CYP2C9—Arachidonic acid metabolism—CYP1B1—glaucoma	4.85e-05	0.00497	CbGpPWpGaD
Zalcitabine—CYP3A5—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	4.82e-05	0.00494	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—SLC4A4—glaucoma	4.58e-05	0.00469	CbGpPWpGaD
Zalcitabine—CYP3A7—Biological oxidations—GSTT1—glaucoma	4.45e-05	0.00456	CbGpPWpGaD
Zalcitabine—SLC22A6—SLC-mediated transmembrane transport—SLC6A1—glaucoma	4.4e-05	0.00451	CbGpPWpGaD
Zalcitabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	4.35e-05	0.00446	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—SLC6A13—glaucoma	4.35e-05	0.00446	CbGpPWpGaD
Zalcitabine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	4.23e-05	0.00433	CbGpPWpGaD
Zalcitabine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	4.19e-05	0.0043	CbGpPWpGaD
Zalcitabine—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	4.17e-05	0.00428	CbGpPWpGaD
Zalcitabine—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	4.14e-05	0.00424	CbGpPWpGaD
Zalcitabine—DCK—Retinoblastoma (RB) in Cancer—TP53—glaucoma	4.13e-05	0.00424	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—CA1—glaucoma	3.84e-05	0.00393	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—CA1—glaucoma	3.78e-05	0.00387	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—CTSA—glaucoma	3.72e-05	0.00381	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—CTSA—glaucoma	3.66e-05	0.00375	CbGpPWpGaD
Zalcitabine—CYP3A7—Biological oxidations—CYP1B1—glaucoma	3.54e-05	0.00363	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—CA2—glaucoma	3.51e-05	0.0036	CbGpPWpGaD
Zalcitabine—CYP3A7—Metapathway biotransformation—CYP1B1—glaucoma	3.49e-05	0.00358	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—CA2—glaucoma	3.46e-05	0.00354	CbGpPWpGaD
Zalcitabine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	3.43e-05	0.00351	CbGpPWpGaD
Zalcitabine—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	3.42e-05	0.0035	CbGpPWpGaD
Zalcitabine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	3.4e-05	0.00348	CbGpPWpGaD
Zalcitabine—CYP3A5—Biological oxidations—GSTT1—glaucoma	3.21e-05	0.00329	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—SLC6A1—glaucoma	3.19e-05	0.00327	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CA5A—glaucoma	3.12e-05	0.00319	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—NARFL—glaucoma	3.12e-05	0.00319	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—SLC6A13—glaucoma	3.05e-05	0.00313	CbGpPWpGaD
Zalcitabine—CYP3A7—Biological oxidations—GSTM1—glaucoma	2.83e-05	0.0029	CbGpPWpGaD
Zalcitabine—CYP3A7—Metapathway biotransformation—GSTM1—glaucoma	2.79e-05	0.00286	CbGpPWpGaD
Zalcitabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	2.76e-05	0.00283	CbGpPWpGaD
Zalcitabine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	2.73e-05	0.0028	CbGpPWpGaD
Zalcitabine—CYP3A5—Biological oxidations—CYP1B1—glaucoma	2.56e-05	0.00262	CbGpPWpGaD
Zalcitabine—CYP3A5—Metapathway biotransformation—CYP1B1—glaucoma	2.53e-05	0.00259	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—TXN—glaucoma	2.47e-05	0.00253	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—TXN—glaucoma	2.43e-05	0.0025	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—GSTT1—glaucoma	2.29e-05	0.00234	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—GSTT1—glaucoma	2.27e-05	0.00232	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—NARFL—glaucoma	2.25e-05	0.00231	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CA5A—glaucoma	2.25e-05	0.00231	CbGpPWpGaD
Zalcitabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	2.24e-05	0.0023	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—SLC6A1—glaucoma	2.23e-05	0.00229	CbGpPWpGaD
Zalcitabine—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	2.19e-05	0.00224	CbGpPWpGaD
Zalcitabine—CYP3A5—Biological oxidations—GSTM1—glaucoma	2.05e-05	0.0021	CbGpPWpGaD
Zalcitabine—CYP3A5—Metapathway biotransformation—GSTM1—glaucoma	2.02e-05	0.00207	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—GSTT1—glaucoma	1.92e-05	0.00196	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—GSTT1—glaucoma	1.89e-05	0.00193	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—CYP1B1—glaucoma	1.82e-05	0.00187	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—CYP1B1—glaucoma	1.81e-05	0.00185	CbGpPWpGaD
Zalcitabine—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	1.8e-05	0.00184	CbGpPWpGaD
Zalcitabine—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	1.78e-05	0.00182	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	1.69e-05	0.00173	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—NARFL—glaucoma	1.6e-05	0.00164	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CA5A—glaucoma	1.6e-05	0.00164	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CA5A—glaucoma	1.59e-05	0.00163	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—NARFL—glaucoma	1.59e-05	0.00163	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—CYP1B1—glaucoma	1.53e-05	0.00157	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—ABCA1—glaucoma	1.53e-05	0.00157	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CA1—glaucoma	1.52e-05	0.00156	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—ABCA1—glaucoma	1.5e-05	0.00154	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—CYP1B1—glaucoma	1.5e-05	0.00154	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—GSTT1—glaucoma	1.49e-05	0.00153	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CTSA—glaucoma	1.47e-05	0.00151	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—GSTM1—glaucoma	1.46e-05	0.00149	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—GSTM1—glaucoma	1.44e-05	0.00148	CbGpPWpGaD
Zalcitabine—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	1.44e-05	0.00147	CbGpPWpGaD
Zalcitabine—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	1.42e-05	0.00146	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CA2—glaucoma	1.39e-05	0.00143	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—GSTM1—glaucoma	1.22e-05	0.00125	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—GSTM1—glaucoma	1.2e-05	0.00123	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—CYP1B1—glaucoma	1.19e-05	0.00122	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	1.17e-05	0.0012	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CA1—glaucoma	1.1e-05	0.00113	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—MTHFR—glaucoma	1.08e-05	0.00111	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CTSA—glaucoma	1.07e-05	0.00109	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—MTHFR—glaucoma	1.06e-05	0.00109	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—NARFL—glaucoma	1.05e-05	0.00107	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CA5A—glaucoma	1.05e-05	0.00107	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CA2—glaucoma	1.01e-05	0.00103	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—APOE—glaucoma	1e-05	0.00103	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—CAV1—glaucoma	9.95e-06	0.00102	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—APOE—glaucoma	9.89e-06	0.00101	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—TXN—glaucoma	9.81e-06	0.001	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—CAV1—glaucoma	9.8e-06	0.001	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—GSTM1—glaucoma	9.52e-06	0.000975	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	9.39e-06	0.000962	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CA1—glaucoma	7.82e-06	0.000802	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CA1—glaucoma	7.75e-06	0.000795	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GSTT1—glaucoma	7.6e-06	0.000779	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CTSA—glaucoma	7.58e-06	0.000776	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—NOS3—glaucoma	7.53e-06	0.000771	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CTSA—glaucoma	7.51e-06	0.00077	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—NOS3—glaucoma	7.41e-06	0.00076	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CA2—glaucoma	7.15e-06	0.000733	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CA2—glaucoma	7.09e-06	0.000727	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—TXN—glaucoma	7.09e-06	0.000726	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	6.93e-06	0.00071	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	6.93e-06	0.00071	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PTGS2—glaucoma	6.88e-06	0.000705	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PTGS2—glaucoma	6.78e-06	0.000695	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ABCA1—glaucoma	6.06e-06	0.000621	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CYP1B1—glaucoma	6.06e-06	0.000621	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GSTT1—glaucoma	5.5e-06	0.000563	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CA1—glaucoma	5.11e-06	0.000524	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—TXN—glaucoma	5.04e-06	0.000517	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—TXN—glaucoma	5e-06	0.000512	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CTSA—glaucoma	4.95e-06	0.000508	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GSTM1—glaucoma	4.84e-06	0.000496	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CA2—glaucoma	4.68e-06	0.000479	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.56e-06	0.000467	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.52e-06	0.000463	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP1B1—glaucoma	4.38e-06	0.000449	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ABCA1—glaucoma	4.38e-06	0.000449	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—MTHFR—glaucoma	4.28e-06	0.000439	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—APOE—glaucoma	3.98e-06	0.000408	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CAV1—glaucoma	3.95e-06	0.000405	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTT1—glaucoma	3.91e-06	0.000401	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTT1—glaucoma	3.87e-06	0.000397	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GSTM1—glaucoma	3.5e-06	0.000359	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—TXN—glaucoma	3.3e-06	0.000338	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.12e-06	0.00032	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ABCA1—glaucoma	3.11e-06	0.000319	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP1B1—glaucoma	3.11e-06	0.000319	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—MTHFR—glaucoma	3.09e-06	0.000317	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP1B1—glaucoma	3.09e-06	0.000316	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ABCA1—glaucoma	3.09e-06	0.000316	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—NOS3—glaucoma	2.99e-06	0.000306	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—APOE—glaucoma	2.88e-06	0.000295	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CAV1—glaucoma	2.85e-06	0.000292	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PTGS2—glaucoma	2.73e-06	0.00028	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTT1—glaucoma	2.56e-06	0.000262	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTM1—glaucoma	2.49e-06	0.000255	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTM1—glaucoma	2.47e-06	0.000253	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—MTHFR—glaucoma	2.2e-06	0.000225	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—MTHFR—glaucoma	2.18e-06	0.000224	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—NOS3—glaucoma	2.16e-06	0.000221	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—APOE—glaucoma	2.05e-06	0.00021	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ABCA1—glaucoma	2.04e-06	0.000209	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP1B1—glaucoma	2.04e-06	0.000209	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—APOE—glaucoma	2.03e-06	0.000208	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CAV1—glaucoma	2.03e-06	0.000208	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CAV1—glaucoma	2.01e-06	0.000206	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PTGS2—glaucoma	1.97e-06	0.000202	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTM1—glaucoma	1.63e-06	0.000167	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—NOS3—glaucoma	1.53e-06	0.000157	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—NOS3—glaucoma	1.52e-06	0.000156	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—MTHFR—glaucoma	1.44e-06	0.000147	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PTGS2—glaucoma	1.4e-06	0.000144	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PTGS2—glaucoma	1.39e-06	0.000143	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—APOE—glaucoma	1.34e-06	0.000137	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CAV1—glaucoma	1.33e-06	0.000136	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—NOS3—glaucoma	1e-06	0.000103	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PTGS2—glaucoma	9.18e-07	9.4e-05	CbGpPWpGaD
